TPEX/6696 (TPEX/6696)

Taipei Exchange: TPEX/6696 · TWD

NT$158

+1.00 (+0.6%)· Recorded snapshot

Market cap	110.3B
Net income (ttm)	-1.6B
EPS (ttm)	-NT$1.94
Shares out	687.2M
Volume	2,506,870
Beta	-0.25

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -1.6B
EPS (ttm): -NT$1.94
Market cap: 110.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-21.8

P25 n/aP50 n/aP75 n/a

ROIC-16

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TPEX/6696 indicators

Market & fundamental data

Available fields

159

Groups with data

Currency

TWD

Showing 159 of 159 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	TWD
Country	Taiwan
Country code	TW
Earnings date	2026-11-13
Enterprise value	TWD 110.1B
Exchange	Taipei Exchange
Financial currency	TWD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Industry	Biotechnology
Is primary listing	Yes
ISIN number	TW0006696008
Last earnings date	2025-11-13
Last refreshed	2026-10-28
Last stock split date	2026-08-31
Last stock split type	Forward
Market cap	TWD 110.3B
Next earnings date	2026-11-13
Price	TWD 157.50
Price currency	TWD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	tpex/6696
Website	https://www.linbioscience.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-1.23%
FCF / EV yield	-2.08%
FCF yield	-2.08%
Industry forward P/E	174.47x
P/B ratio	4.31x
Price / tangible book value	10.52x
Sector forward P/E	28.08x
Sector P/E	83.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-15.73%
ROA (5Y)	-19.29%
ROCE	-15.49%
ROE	-21.83%
ROE (5Y)	-39.84%
ROIC	-16%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	TWD -26.1M
Depreciation and amortization	TWD 8.9M
EBIT	TWD -4B
EBITDA	TWD -4B
EPS	TWD -1.94
FCF per share	TWD -3.33
Financing cash flow	TWD 20.6B
Free cash flow	TWD -2.3B
Free cash flow minus SBC	TWD -3.7B
Income taxes	TWD -53.6M
Investing cash flow	TWD -11.3B
Net borrowing	TWD -21.5M
Net cash flow	TWD 8B
Net income	TWD -1.6B
Operating cash flow minus SBC	TWD -3.7B
Operating income	TWD -4B
Stock-based compensation	TWD 1.4B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	TWD 12.78
Debt / equity	0
Interest coverage	-2,058.26
Long-term assets	TWD 9.2B
Long-term liabilities	TWD 64.7M
Net cash (debt)	TWD 16.5B
Net cash / market cap	14.96%
Net cash growth	217.75%
Net debt / equity	-0.65
Piotroski F-Score	0
Property, plant and equipment	TWD 111.1M
Shareholders' equity	TWD 25.6B
Tangible book value	TWD 10.5B
Tangible book value per share	TWD 12.64
Total assets	TWD 26.1B
Total cash	TWD 16.6B
Total debt	TWD 92.7M
Total liabilities	TWD 507.4M
WACC	2.89%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	TWD 16.9B
Current liabilities	TWD 442.7M
Current ratio	38.08
Net working capital	TWD -154.7M
Quick ratio	37.54
Working capital	TWD 16.4B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.46%
Shareholder yield	-3.46%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	TWD 78.09
1D price change	0.64%
1M price change	-20.96%
1M total return	-20.96%
1W price change	-7.94%
1W total return	-7.94%
1Y price change	435.96%
1Y return CAGR	436.58%
1Y total return	435.96%
20-day SMA	TWD 172.55
200-day SMA	TWD 68.36
3M price change	123.25%
3M total return	123.25%
3Y price change	1,204.17%
3Y return CAGR	135.87%
3Y total return	1,212.94%
50-day SMA	TWD 144.22
50-day SMA vs 200-day SMA	50over200
52-week high	TWD 207.00
52-week high date	2026-09-23
52-week low	TWD 24.70
52-week low date	2025-10-30
5Y price change	1,094.66%
5Y return CAGR	65.21%
5Y total return	1,130.41%
6M price change	281.71%
6M total return	281.71%
All-time high	TWD 207.00
All-time high date	2026-09-23
All-time low	TWD 2.70
All-time low date	2019-11-18
Average true range (ATR)	TWD 12.70
Average volume	6M
Beta (1Y)	0.25
Beta (2Y)	0.57
Beta (5Y)	-0.25
Change from 52-week high	-23.91%
Change from 52-week low	537.65%
Change from all-time high	-24.4%
Change from all-time low	5,696.3%
Change from open	-0.94%
Day's gap	1.6%
Dollar volume	TWD 394.8M
High price	TWD 161.50
Low price	TWD 156.00
Monthly RSI	77.83
Open price	TWD 159.00
Position in 52-week range	27.27%
Previous close	TWD 156.50
Price vs 150-day SMA	100.41%
Price vs 20-day SMA	-9.3%
Price vs 200-day SMA	128.94%
Price vs 50-day SMA	8.51%
Relative volume	0.42
RSI	45.89
Sharpe ratio	2.96
Sharpe ratio (3Y)	1.51
Sharpe ratio (5Y)	0.97
Sortino ratio	7.07
Sortino ratio (3Y)	3.14
Sortino ratio (5Y)	1.95
Volume	2.5M
Weekly RSI	77.21
YTD price change	294.21%
YTD total return	294.21%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	638.6M
Shares change (QoQ)	0.18%
Shares change (YoY)	3.46%
Shares held by insiders	22.38%
Shares held by institutions	8.34%
Shares outstanding	687.2M

Deeper analysis on TPEX/6696

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TPEX/6696 report

Is a complete TPEX/6696 research report available?

No complete published report is available for tpex/6696 (TPEX/6696) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TPEX/6696 (TPEX/6696)

Price

Financial snapshot

Fair-value bridge

Latest news · TPEX/6696

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TPEX/6696 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TPEX/6696

Frequently asked questions